Skip Navigation



European Heart Journal Advance Access published online on May 22, 2006

European Heart Journal, doi:10.1093/eurheartj/ehl013
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Supplementary colour figures
Right arrow All Versions of this Article:
27/15/1868    most recent
ehl013v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Neilan, T. G.
Right arrow Articles by Scherrer-Crosbie, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neilan, T. G.
Right arrow Articles by Scherrer-Crosbie, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2006; all rights reserved
Received October 17, 2005
Revised April 7, 2006
Accepted April 13, 2006

Preclinical research

Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury

Tomas G. Neilan 1, Davinder S. Jassal 2, Teresa M. Perez-Sanz 2, Michael J. Raher 3, Aruna D. Pradhan 4, Emmanuel S. Buys 3, Fumito Ichinose 3, David B. Bayne 3, Elkan F. Halpern 5, Arthur E. Weyman 2, Geneviéve Derumeaux 6, Kenneth D. Bloch 3, Michael H. Picard 2, and Marielle Scherrer-Crosbie 1 *

1 Cardiac Ultrasound Laboratory, Harvard Medical School, USA; Cardiovascular Research Center, Cardiology Division of the Department of Medicine, Harvard Medical School, USA
2 Cardiac Ultrasound Laboratory, Harvard Medical School, USA
3 Cardiovascular Research Center, Cardiology Division of the Department of Medicine, Harvard Medical School, USA
4 Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, USA
5 Institute for Technology Assessment, Massachusetts General Hospital, USA
6 Department of Cardiology, Hospital Louis Pradel, Lyon, France

* To whom correspondence should be addressed.
Marielle Scherrer-Crosbie, E-mail: marielle{at}crosbie.com


   Abstract

Aims Currently available non-invasive imaging methods frequently fail to detect alterations in left ventricular (LV) function despite histological evidence of injury. Tissue Doppler imaging (TDI) can detect subtle LV dysfunction. The aim of this study was to investigate whether TDI indices can predict LV systolic dysfunction and mortality following exposure to doxorubicin (DOX) in mice.

Methods and results TDI-derived peak endocardial systolic velocity (VENDO) and strain rate (SR), as well as M-mode and two-dimensional indices of LV systolic function, were measured serially in mice after receiving DOX as a single dose (20 mg/kg). Haemodynamic measurements were obtained invasively before and at 1, 2, 4, and 5 days after the single DOX dose. Cardiac apoptosis was measured before and at 1 day after DOX. VENDO and SR decreased after 1 and 2 days, respectively, whereas changes in fractional shortening (FS) and LV ejection fraction (LVEF) were not detected before 5 days. The reduction in both VENDO and SR correlated with the decrease in dP/dtMAX, and the change in VENDO correlated with the early increase in cardiac cell apoptosis. In a subsequent experiment, DOX was administered at 4 mg/kg/week for 5 weeks, and LV function was followed serially for 16 weeks. In this chronic experiment, TDI indices decreased before FS and LVEF, correlated with late LV dysfunction, and predicted DOX-induced mortality.

Conclusion In a murine model of DOX-induced cardiac injury, TDI detects LV dysfunction prior to alterations in conventional echocardiographic indices and predicts mortality. This study suggests that TDI may be a reliable tool to detect early subtle changes in DOX-induced cardiac dysfunction.

Keywords: Echocardiography; Tissue Doppler imaging; Doxorubicin; Apoptosis; Heart failure.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Peng, Z. B. Popovic, N. Sopko, J. Drinko, Z. Zhang, J. D. Thomas, and M. S. Penn
Speckle tracking echocardiography in the assessment of mouse models of cardiac dysfunction
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H811 - H820.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Mukhopadhyay, M. Rajesh, S. Batkai, Y. Kashiwaya, G. Hasko, L. Liaudet, C. Szabo, and P. Pacher
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1466 - H1483.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
K. George, R. Shave, D. Oxborough, T. Cable, E. Dawson, N. Artis, D. Gaze, T. Hew-Butler, K. Sharwood, and T. Noakes
Left ventricular wall segment motion after ultra-endurance exercise in humans assessed by myocardial speckle tracking
Eur J Echocardiogr, March 1, 2009; 10(2): 238 - 243.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
G. Derumeaux, F. Ichinose, M. J. Raher, J. G. Morgan, T. Coman, C. Lee, J. M. Cuesta, H. Thibault, K. D. Bloch, M. H. Picard, et al.
Myocardial Alterations in Senescent Mice and Effect of Exercise Training: A Strain Rate Imaging Study
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 227 - 234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Huebner, D. S. Jassal, O. Halevy, M. Pines, and J. E. Anderson
Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1550 - H1561.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Mukhopadhyay, S. Batkai, M. Rajesh, N. Czifra, J. Harvey-White, G. Hasko, Z. Zsengeller, N. P. Gerard, L. Liaudet, G. Kunos, et al.
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity
J. Am. Coll. Cardiol., August 7, 2007; 50(6): 528 - 536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Thibault, L. Gomez, E. Donal, G. Pontier, M. Scherrer-Crosbie, M. Ovize, and G. Derumeaux
Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H496 - H502.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Ballo, A. Bocelli, and S. Mondillo
Adaptive and Maladaptive Cardiac Hypertrophy: What Is the Effective Role of Heat Shock Transcription Factor 1?
Circ. Res., February 16, 2007; 100(3): e45 - e46.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. G. Neilan and D. J. Fitzgerald
Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumor suppression: reply
Eur. Heart J., November 1, 2006; 27(21): 2611 - 2611.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F. Weidemann and J. M. Strotmann
Detection of subclinical LV dysfunction by tissue Doppler imaging
Eur. Heart J., August 1, 2006; 27(15): 1771 - 1772.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.